Saratoga Health & Biotechnology Portfolio Fund Class C logo

Saratoga Health & Biotechnology Portfolio Fund Class C (SHPCX)

Market Closed
13 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
15. 16
-0.07
-0.4596%
$
- Market Cap
- Div Yield
0 Volume
$ 15.23
Previous Close
Add Transaction
Day Range
15.16 15.16
Year Range
12.62 15.38
Want to track SHPCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SHPCX closed today lower at $15.16, a decrease of -0.4596% from yesterday's close, completing a monthly increase of 3.9068% or $0.57. Over the past 12 months, SHPCX stock gained 8.2857%.
SHPCX pays dividends to its shareholders, with the most recent payment made on Dec 11, 2024. The next estimated payment will be in 11 Dec 2024 on Dec 11, 2024 for a total of $0.253.
The stock of the company had never split.
The company's stock is traded on one exchange.

SHPCX Chart

Saratoga Health & Biotechnology Portfolio Fund Class C (SHPCX) FAQ

What is the stock price today?

The current price is $15.16.

On which exchange is it traded?

Saratoga Health & Biotechnology Portfolio Fund Class C is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is SHPCX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Saratoga Health & Biotechnology Portfolio Fund Class C ever had a stock split?

No, there has never been a stock split.

Saratoga Health & Biotechnology Portfolio Fund Class C Profile

NASDAQ (NMS) Exchange
United States Country

Overview

The fund is an investment vehicle that primarily focuses on the healthcare and biotechnology sectors, encompassing a variety of companies from the United States and abroad. It aims to invest a significant portion of its assets, at least 80%, in equity securities, including common and preferred stocks, as well as securities convertible into common stocks and warrants, of these healthcare and biotechnology companies, without a bias towards any specific market capitalization. The investment strategy is governed by a top-down approach, emphasizing long-term economic trends to guide its selections. This method allows the fund to identify and capitalize on global developments and sector dynamics that are expected to drive growth in the healthcare and biotechnology spaces.

Products and Services

  • Equity Securities of Healthcare Companies
  • This product focuses on investing in the common stocks, preferred stocks, convertible securities, and warrants of U.S. and foreign healthcare companies. The aim is to leverage the growth potential of the healthcare sector, driven by innovation, regulatory changes, and increasing demand for healthcare services worldwide.

  • Equity Securities of Biotechnology Companies
  • Similar to its approach with healthcare companies, the fund invests in equity securities of biotechnology firms. These investments are directed at companies engaged in the research, development, and commercialization of innovative medical treatments and technologies. Biotechnology investments are chosen based on their potential for substantial growth, benefitting from advancements in science and increasing healthcare needs.

  • Adviser's Top-down Investment Approach
  • The fund's investment adviser employs a top-down approach to portfolio management. This strategy begins with an analysis of global economic trends, identifying those with the potential to significantly impact the healthcare and biotechnology sectors. The adviser then selects investments that are well-positioned to benefit from these trends over the long term, focusing on sustainable growth opportunities.

Contact Information

Address: Omaha, Nebraska 68137
Phone: -